To date, a number of reports have been published on the relation of cigarette smoking to age-related maculopathy, an important cause of blindness in the United States. However, few studies have examined the relation between smoking and the incidence of age-related maculopathy. In this report, the authors examine this association in persons aged 43-86 years (n = 3,583) at baseline who were participants in the baseline examination and 5-year follow-up of the Beaver Dam Eye Study, Beaver Dam, Wisconsin (1988 -1990 -1995 . Exposure data on cigarette smoking were obtained from questions about present and past smoking, duration of smoking, and the number of cigarettes smoked per day. Age-related maculopathy status was determined by grading stereoscopic color fundus photographs using the Wisconsin Age-related Maculopathy Grading System. After controlling for age, sex, vitamin supplement use, and beer consumption, men who smoked greater amounts of cigarettes were more likely to develop early age-related maculopathy (odds ratio (OR) per 10 pack-years smoked = 1.06, 95% confidence interval (Cl) 1.00-1.13, p = 0.06) than men who had smoked less. This association was not observed in women. Men (OR = 3.21, 95% Cl 1.09-9.45) and women (OR = 2.20, 95% Cl 1.04-4.66) who were current smokers at the time of the baseline examination had significantly higher odds of developing large drusen (>250 /xm in diameter) after 5 years than those who had never smoked or who quit before the baseline study. Current or past history of cigarette smoking was not related to the incidence of retinal pigment epithelial depigmentation. The authors conclude that smoking appears to be related to the incidence of some lesions associated with early age-related maculopathy. Am J
Age-related maculopathy (ARM), a leading cause of blindness in residents of the United States aged 65 years or older, is estimated to affect 16-26 percent of people in this age group (1) (2) (3) (4) (5) (6) . At present, there are no medical interventions which have been shown to prevent the incidence or progression of this disease. Photocoagulation may prevent severe loss of vision in only the small percent of patients who develop the late exudative stage of this disease (7) . Other surgical interventions have not been shown to be effective in preventing loss of vision from late age-related maculopathy (8) . For these reasons, identification of factors
The methods used to identify the population and descriptions of the population have been published elsewhere (20, 21) . A private census of the population of Beaver Dam, Wisconsin, was performed from September 15, 1987 to May 4, 1988 to identify all residents in the city or township of Beaver Dam who were aged 43-84 years. Of the 5,924 eligible individuals, 4,926 participated in the baseline examination between March 1,1988 and September 14, 1990 . Ninety-nine percent of the population was white. Nonparticipants consisted of 226 persons (3.8 percent) who had died before the examination, 18 (0.3 percent) who could not be located, 337 (5.7 percent) who permitted an interview only (of these, 61 had moved), and 417 (7.0 percent) who refused to participate (of these, 39 had moved). Comparisons between participants and nonparticipants at the time of the baseline examination have appeared elsewhere (21) .
Prior to the start of the 5-year follow-up examination on March 1, 1993 , 385 (7.8 percent) of the participants had died. Of the 4,541 surviving participants in the baseline examination, 3,684 (81.1 percent) participated in the follow-up examination between March 1,1993 through June 14, 1995. Four participants could not be located, 259 (5.7 percent) permitted an interview only (of these, 48 had moved out of the area), 423 (9.3 percent) refused to participate (of these, 44 had moved out of the area), and 171 died during the examination period. Both the mean and median times between the baseline and 5-year follow-up examinations were 4.8 years (standard deviation, 0.4 years).
Comparisons between participants and nonparticipants at follow-up have been presented elsewhere (22) . Persons who were alive and who did not participate in the follow-up eye examination (n = 686) were older at baseline than those who did participate (62.7 vs. 60.4 years, p < 0.0001). After adjusting for age, persons who were alive during the study period and who did not participate were more likely than persons who participated to have fewer years of education completed, lower income, poorer visual acuity, a history of cardiovascular disease, a history of never drinking alcohol, higher serum cholesterol, and higher systolic and diastolic blood pressure, to have smoked more, and to be retired at baseline. After adjusting for age and sex, participants with early ARM at baseline were more likely to participate than those in whom ARM was absent (Cochran-Mantel-Haenszel test for general association, p = 0.003).
Procedures
Similar procedures were used at the baseline and follow-up examinations. The procedures used have been described in detail elsewhere (20) (21) (22) (23) (24) (25) (26) (27) . Informed consent was obtained from each participant at the beginning of the examination. Pertinent parts of the examination at both baseline and follow-up consisted of taking stereoscopic 30° color fundus photographs centered on the disc (Diabetic Retinopathy Study (DRS) standard field 1), macula (DRS standard field 2), and a non-stereoscopic color fundus photograph temporal to but including the fovea of each eye. For purposes of this report, the 3,583 people with at least one eye free of confounding lesions (e.g., retinal detachment or non-age-related chorioretinal scarring) at both examinations (right eye, n = 3,497; left eye, n = 3,519; both eyes, n = 3,435) are included in the analyses (28) .
The Wisconsin Age-Related Maculopathy Grading System was used to assess the presence and severity of lesions associated with ARM. Grading procedures, lesion descriptions, and detailed definitions for the presence and severity of specific lesions have appeared elsewhere (25) (26) (27) . Detailed definitions for incidence of specific lesions have also appeared elsewhere (28) . In brief, incidence implies the appearance of a lesion at follow-up when it was absent at baseline. Progression implies the presence of a lesion at baseline with a worsening at follow-up (28) .
Incidence was determined for maximum size and type of each specific drusen class, increased retinal pigment, retinal pigment epithelial (RPE) depigmentation, signs of exudative macular degeneration, and pure geographic atrophy. Incidence of a specific type of lesion was defined by the presence of such a lesion when it was not there at baseline in any of the subfields that could be graded at both examinations. For example, if none of the subfields had soft indistinct drusen at baseline and soft indistinct drusen was present in one or more subfields at follow-up, the eye would be considered to have "incident" soft indistinct drusen. Incidence of a lesion for a participant was defined by not having the lesion in any subfield in either eye at baseline and developing it in at least one subfield at follow-up.
The incidence of early ARM was defined by the presence of either soft indistinct drusen or the presence of any type of drusen associated with RPE depigmentation or increased retinal pigment at follow-up when none of these lesions was present at baseline. The incidence of late ARM was defined by the appearance of either exudative macular degeneration or pure geographic atrophy at follow-up when neither was present at baseline.
For each eye, a six-level severity scale for agerelated maculopathy was defined as follows: Progression for a participant was defined as an increase in the maculopathy severity in either eye by two steps or more from level 10 through level 30 and one step or more from level 40 or level 50 at the 5-year follow-up examination.
Age was defined as the age at the time of the baseline examination. Cigarette smoking status at the time of the baseline examination was determined as follows. A subject was classified as a nonsmoker if he/she had smoked < 100 cigarettes in his/her lifetime; as a former smoker if he/she had smoked more than this number of cigarettes in his/her lifetime but had stopped smoking before the examination; and as a current smoker if he/she had not stopped smoking. Total pack-years smoked was defined as the number of cigarettes smoked per day divided by 20, multiplied by the number of years smoked. Of the 3,684 persons who participated in the baseline and follow-up examinations, one was missing information on smoking status and 12 persons were missing pack-year information.
Statistical methods
For these analyses, we examined the relations between smoking status and pack-years smoked to the incidence or progression of each of the specific maculopathy lesions and to the incidence of three endpoints of disease severity: early ARM, exudative macular degeneration, and late ARM. For the incidence of exudative macular degeneration and late ARM, analyses were restricted to those who were aged 65-86 years at baseline and who had early ARM. There was only one person with no ARM at baseline who developed late ARM at follow-up and there were only three persons who were aged 43-64 at baseline who developed late ARM at follow-up. SAS Institute software was used for calculating chi-square statistics (29) . Tests for trends in proportions were performed with the Mantel-Haenszel procedure (30) . Logistic regression was used to determine whether smoking status or pack-years smoked predicted the incidence of signs of ARM while controlling for age, sex, vitamin supplement use, and beer consumption (31) . In these models, smoking status was considered using two indicator variables (former smoker vs. never smoked and current smoker vs. never smoked). Table 1 shows cigarette smoking status and packyears smoked at baseline by age and sex. Among persons who reported a history of smoking, a larger proportion of current smokers were in the younger age groups, whereas the proportion of former smokers increased with each older age group. Men were more likely than women to smoke or to have smoked (p < 0.0001). Because the patterns of smoking differed between men and women and by age, we examined the relations between smoking and ARM separately for men and women. The age-adjusted incidence of early ARM, lesions associated with various manifestations of ARM, exudative macular degeneration, and late ARM by smoking status are shown in table 2 separately for men and women. As shown in the third set of columns, after controlling for age, men who reported they were currently smoking at baseline were 4.75 times (95 percent confidence interval (CI) 1.60-14.10) more likely to develop large soft drusen (^250 ixm in diameter) than those who had never smoked; for women, the relative risk was 1.90 (95 percent CI 0.98-3.69). After controlling for age, men who smoked at baseline had almost twice the incidence or progression of RPE depigmentation (relative risk (RR) = 1.91, 95 percent CI 1.01-3.62) compared with men who had never smoked. This association was not found in women (p > 0.05). There was no significant association of smoking to incidence or progression of soft indistinct drusen or increased retinal pigment in either men or women (data not shown). There was a significant association between smoking and increased risk of progression of ARM among male current smokers only. No statistically significant {p > 0.05) associations between smoking status and the incidence of other lesions associated with ARM were found.
RESULTS
There was a significant increase in the age-adjusted incidence of developing large soft drusen with increasing number of pack-years smoked in men (p test of trend = 0.01) and in women (p test of trend = 0.01). Number of pack-years smoked at baseline was also related to the incidence of increased retinal pigment (p test of trend = 0.04) and to progression of ARM (p test of trend = 0.01) in men but not in women. Pack-years of smoking was not related to incidence of other ARM lesions.
To determine whether smoking status or pack-years smoked made a significant contribution to the incidence and progression of ARM or specific lesions associated with ARM after controlling for other factors, separate multiple logistic regression models were developed for men and women. Incidence of early ARM and the specific lesions were considered as separate dependent variables. After including age, beer consumption, and vitamin supplement use at baseline as independent variables, smoking status and packyears were included in separate models. For both men and women, a history of current or past smoking was associated with an increased incidence of large soft drusen (table 3) . Men who had smoked for more pack-years were more likely to develop increased ret- * Incidence is defined as the cumulative incidence of a lesion at the follow-up examination among subjects without the lesion at baseline.
t Controlling for age, vitamin supplement use, and beer consumption. i OR, odds ratio; Cl, confidence interval; RPE, retinal pigment epithelial. § Applies to the set of indicator variables (former and current smokers) defining smoking status.
inal pigment and early ARM than those who had smoked fewer pack-years; however, this association with early ARM failed to reach statistical significance. Men who were current smokers at baseline or who had smoked more pack-years were more likely to have progression of ARM than men who had never smoked or who had smoked less over their lifetime. There were too few individuals who developed signs of late ARM to do multivariable regression models to examine the relation with cigarette smoking.
DISCUSSION
These findings suggest that cigarette smoking is related to the development of large soft drusen which are strongly predictive of development of signs of late ARM (28, 32) . Smoking, by depressing antioxidants (33, 34) and causing alterations in choroidal blood flow (35, 36) , has been hypothesized to be involved in the pathogenesis of ARM.
It is possible that smoking itself may be a risk indicator for other factors that have been associated with ARM, such as alcohol consumption and vitamin supplement use (37) (38) (39) . However, the relation of smoking to the incidence and progression of these early ARM lesions remained after controlling for some of these factors.
In Beaver Dam, Wisconsin, cigarette smoking was associated with the progression of ARM only in men. Similarly, Hyman et al. (10) found a significant relation of late ARM only in men in their case-control study in Baltimore, Maryland. Approximately 71 percent of men and 42 percent of women gave a history of smoking in Beaver Dam compared with 74 percent of men and 39 percent of women in the study by Hyman et al. (10) . The failure to find an association among women in both studies may have been due to a lower frequency of cigarette smoking in women compared with men. Sex differences in how well reported current history of smoking reflects past exposure history may partially explain the discrepant patterns between women and men.
In the Beaver Dam population, smoking appeared to be related to the development of some signs of early ARM, but it was not related to the development of signs of late ARM. This finding stands in contrast to the data of our earlier cross-sectional study (12) and to those of other epidemiologic studies (9) (10) (11) (13) (14) (15) (16) which have shown a relation. The reason we did not find a relation between cigarette smoking and the development of exudative macular degeneration or geographic atrophy may be due to the low 5-year incidence of these late stages of ARM in the Beaver Dam population and consequently the small number of cases available for analysis. It is possible that selective survival is a reason for not finding a relation of smoking to incident ARM. However, we have not found a relation between measures of ARM and increased risk of mortality (40) .
To our knowledge, there exist few other longitudinal data to compare with these findings. A prospective study of nurses aged 50 years or older (13) found a significant relation of pack-years smoked at baseline to increasing relative risk of self-reported physicianconfirmed cases of ARM (early and late) developing over a 12-year period. After adjusting for other factors, it was found that women who were current smokers of &25 cigarettes per day were 2.4 times as likely to report development of late ARM compared with women who had never smoked. The authors also found a similar relation for past history of smoking relative to having never smoked. There also appeared to be an increasing risk of developing late ARM with increasing number of pack-years smoked. Similarly, in the Physicians' Health Study, a significant relation of smoking to development of late ARM was found (14) . In that study, men who were current smokers of S20 cigarettes per day were 2.5 times as likely to report developing age-related macular degeneration compared with men who had never smoked. However, in a follow-up study of 670 patients enrolled in the Macular Photocoagulation Study (MPS), the MPS Study Group reported no relation of cigarette smoking to the risk of developing choroidal new vessels in unaffected fellow eyes (41) .
In summary, in Beaver Dam, Wisconsin, we found an apparent association between smoking and the incidence of some lesions that are associated with early age-related maculopathy. The associations appeared to be stronger in men than in women. Further follow-up of this aging cohort will provide an ability to examine the relation of smoking to late ARM. Until then, data from cross-sectional studies and from some large cohort studies suggest that it would be prudent to counsel patients with signs of early age-related maculopathy to stop smoking.
